The Role of PD-L1 Testing in Advanced Genitourinary Malignancies.
Sign Up to like & getrecommendations! Published in 2019 at "European urology focus"
DOI: 10.1016/j.euf.2019.03.003
Abstract: In accordance with US Food and Drug Administration recommendations, tumor PD-L1 expression should be assessed in all patients with platinum-ineligible metastatic urothelial carcinoma (mUC), and patients with low PD-L1 expression should not receive single-agent immune… read more here.
Keywords: advanced genitourinary; genitourinary malignancies; role testing; urology ... See more keywords
Distress and Quality of Life Among Patients with Advanced Genitourinary Cancers.
Sign Up to like & getrecommendations! Published in 2019 at "European urology focus"
DOI: 10.1016/j.euf.2019.10.014
Abstract: Patients with advanced genitourinary cancers face many challenges throughout their disease trajectory, and many will experience clinically relevant psychosocial distress. Certain groups, including female gender, younger age (and older age for suicide), unmarried status, and… read more here.
Keywords: risk; advanced genitourinary; patients advanced; quality life ... See more keywords
Prognostic understanding in advanced genitourinary cancer and its association with clinical characteristics.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.665
Abstract: 665Background: Despite promotion of a shared decision-making model of care in oncology, studies suggest that many patients with advanced cancer still possess inaccurate perceptions of their prognos... read more here.
Keywords: prognostic understanding; advanced genitourinary; genitourinary cancer; cancer ... See more keywords